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CHAPTER I 
INTRODUCTION 
Coronary heart disease is the single leading cause of death worldwide, accounting for 7.0 
million deaths, or 11.2% of all deaths annually(“WHO | The top 10 causes of death,” n.d.). It is 
also the most common cause of death in the United States. There are many negative sequelae 
of coronary artery disease, including acute coronary syndrome (ACS). Each year, coronary 
artery disease affects more than 16 million Americans, from which there are between 6 and 10 
million visits to US emergency departments for suspected ACS, of which only 1.36 million 
hospitalizations are for true ACS cases. While the most conservative estimates suggest that the 
United States spends 3 to 5 billion dollars per year for the cost of effectively managing the 
patients who present with symptoms of ACS but ultimately received a different diagnosis, 
others purport that the true number may be 10 to 15 billion dollars. This is in addition to the 
165 billion dollars of direct and indirect costs due to true cases of ACS (Limkakeng & Gibler, 
2001; Marcoon, Chang, Lee, Salhi, & Hollander, 2013). 
ACS includes unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI) 
and ST-segment elevation myocardial infarction (STEMI). These three acute manifestations of 
coronary artery disease share a common pathophysiology related to atherosclerosis, or plaque 
formation in medium- and large-sized blood vessels, and cause symptoms through a disparity 
between cardiac supply and demand of oxygen. They are classified on the basis of their severity 
and duration of symptoms.  UA is typically neither severe nor prolonged, but occurs at rest.  It is 
differentiated from myocardial infarction (MI) on the basis of elevated cardiac markers, as well 
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as a typically longer duration of symptoms for myocardial infarction. In turn, myocardial 
infarction is differentiated between ST-segment elevated myocardial infarction and non-ST-
segment on the basis of electrocardiogram (ECG) findings.  
The disease process begins with damage to the endothelial layer of the vessels, which results in 
vascular hemostasis, increased expression of adhesion molecules, and increased 
thrombogenicity of the blood. Once the endothelium of the vessels is damaged, inflammation is 
the primary mechanism for the development of a plaque. Inflammatory cells, especially 
monocytes, invade into the subendothelial space. There, they differentiate into macrophages. 
These macrophages, which are typically thought of as “cleanup cells” of the immune system, 
start to digest the low density lipoprotein, otherwise known as “bad cholesterol”, and develop 
into foam cells. This transformation causes the development of fatty streaks along the walls of 
the blood vessels, a process that has been shown to begin as early as the first decade of life. 
Through the macrophage release of chemoattractants and cytokines, this inflammatory process 
continues to build on itself(Kumar & Cannon, 2009).  
The stability of these plaques is highly variable. However, when plaques are disturbed, they can 
rupture or erode. In either case, the subendothelial matrix that has been secreted by the 
macrophages is exposed, leading to platelet adhesion, platelet activation, and aggregation, and 
then to the development of a thrombus, or clot.  Autopsy studies have shown that plaque 
rupture causes 75% of fatal myocardial infarctions, while the remaining 25% results from 
superficial erosion to the subendothelial matrix. It is of note that not all atherosclerotic plaques 
rupture, and that not all ruptured plaques cause clinically visible ACS. The Framingham study 
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was the first to show that 99% of all ruptures are clinically silent, and often never noticed by the 
patients. Progression of these plaques, including their potential to cause ACS, is variable, non-
linear, and unpredictable.  
Once the subendothelium has been exposed, two types of clots can form. A platelet rich 
“white” clot can form, more often at areas of high shear stress, while “red” fibrin clots form 
where there is activation of the clotting cascade.  Often, a red clot will form superimposed on a 
white clot.  At least one study has shown a differential clotting type among ACS, with white 
clots found more often in UA/NSTEMI cases and red clots more often in STEMI events.  
Just as there is variability in the stability plaques that progress into cases of ACS, there are 
many different ways in which a patient may present to physician when they do experience an 
ACS event.  Many patients present to the emergency department of hospitals, which may be 
the only place they are guaranteed of receiving medical attention, and chest pain is the second 
most common presenting complaint in the emergency department. The variability of 
presentation includes often atypical presentations, and there is a large overlap between the 
presenting symptoms of a patient with ACS and patients with diseases of non-cardiac etiology 
(Scirica, 2010). To appropriately diagnose ACS, physicians rely on many different testing 
modalities.  Cardiac markers, electrocardiographic readings, stress tests and coronary 
angiography are all employed to rule in or out the presence of ACS.   However, these tests are 
all individually less than ideal for this purpose. As a result, between 2 and 5% of patients with 
true ACS are examined in the emergency room, reported to have non-specific findings not 
indicative of cardiac disease, and mistakenly discharged from the emergency room. This error 
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confers nearly twice the risk of 30-day mortality (Pope, Aufderheide, & Ruthazer, 2000).  
Furthermore, a missed diagnosis of ACS can be costly for a physician or hospital. Data from the 
Physician Insurers Association of America shows that 26% of all malpractice claims in 
emergency departments from 1985 to 2003 were for patients evaluated for chest pain, and 
other estimates put the amount of money for such claims at greater than 25% of all medical 
malpractice dollars paid to plaintiffs (Rusnak, Stair, Hansen, & Fastow, 1989; Strehlow, 2011).  
In response to the uncertain variability of patient presentation, and often in fear of life-
endangering medical errors and malpractice litigation, emergency room doctors are often left 
with the only option of performing a full gamut of tests on every patient who presents to the 
emergency room with chest pain.  Of patients worked up for and admitted to the hospital for 
ACS, only 30% are determined to have a cardiac origin for their symptoms.  The workup of 
patients with suspected ACS who turn out not to have ACS is the  main driver for the 3 to 15 
billion dollars spent annually to accurately diagnose patients with unclear chest pain symptoms. 
In an ideal world, all patients with ACS would be admitted and all patients without ACS would 
be discharged promptly or treated for the true reason for their emergency visit.  
One approach to reducing unnecessary expenditure in the treatment of patients with suspected 
ACS is the use of risk stratification.  Predicting the probability of a major adverse event for 
patients who present with chest pain is recommended in guidelines published by the American 
College of Cardiology and American Heart Association. It is also largely accomplished by the 
same tests used in making a diagnosis of ACS(Anderson et al., 2011). 
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To further assist physicians in evaluating patients with potential ACS, a multitude of prognostic 
algorithms, indices and tools have been developed which combine the individual results of tests 
to predict the likelihood of a negative outcome for a patient, and can help to give structure to 
the often unstructured process of diagnosis.  In the following chapter, this tradition of risk 
stratification for the purposes of determining which patients are safe for discharge and which 
patients will require more intensive therapies is presented in some depth.  
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CHAPTER II 
BACKGROUND 
A fully exhaustive cataloging of the attempts to stratify patients with potential acute coronary 
syndrome on the basis of their underlying risk, and the performances of these various 
approaches, is well beyond the scope of this document. A useful (though also not 
comprehensive) reference can be found in (Than, Flaws, Cullen, & Deely, 2013).  However, it is 
instructive to describe in some detail several of the tools, algorithms and prognostic indices 
that have been developed over the past fifty years, examine their successes and shortcomings, 
and show how the lessons learned from prior work influenced this current research.  Many of 
these threads of research took place simultaneously, but for the purpose of this writing, will be 
presented in terms of continuous work on individual research lines. 
Many of the algorithms described here will focus solely on MI because the combining of UA and 
MI into the clinical entity of ACS is a rather recent development. As such, many of the 
algorithms described here will focus solely on myocardial infarction.  Current clinical practice 
treats these two diseases as gradations along one spectrum of pathophysiology. 
Early Methods 
In 1962, Peel et al. proposed potentially the first numeric prognostic index for grading the 
severity of myocardial infarctions. While their initial scoring methodology was based on purely 
clinical experience, they did revisit the data, weighting the individual factors appropriately 
based on likelihood ratios determined from one set of 260 patients (Peel, Semple, Wang, 
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Lancaster, & Dall, 1962).  The variables included in their model were age, sex, previous history, 
presence and degree shock and heart failure, cardiac rhythm, and cardiographic signs. While 
this index was designed and used for grading confirmed (not suspected) myocardial infarction, 
it set the precedent for the inclusion of ‘clinically meaningful’ factors, and, in many ways, the 
methodology for how these factors should be approached mathematically. They may have also 
set a precedent for considering the output of prognostic indices as “binned”, as their table of 
output for the validation and derivation series show explicit divisions in the index that they 
deemed clinically meaningful.  
In 1968, Pipberger et al. presented the results of a pilot study to use new computer technology 
to quantitatively examine signs, symptoms and laboratory tests of patients and determine if a 
computer could perform a simplified differential diagnosis and correctly classify patients with 
coronary artery disease versus patients with pneumonia. Their data set consisted of 1238 
patients admitted with a chief complaint of chest pain, each with 429 binary “yes-no” variables 
and 69 numeric variables.  They included only those variables that appeared in at least 25% of 
cases for the disease groups they were interested in, and then further limited the number of 
potential variables by means of univariate chi squared testing. This serial reduction yielded a 
final 26 variables, most of which were related to current symptoms, which they utilized for 
linear discriminant analysis, a technique closely related to logistic regression.  Their method 
resulted in correct classification for 77% of the patients with coronary artery disease, and 79% 
of the patients with pneumonia. Their success was likely due to the high quality of the histories 
collected on these patients (Pipberger, Klingeman, & Cosma, 1968). 
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ACI-TIPI 
The work that led to the development of the acute cardiac ischemia time-insensitive predictive 
instrument (ACI-TIPI) began in the late 1970s.  As previously mentioned, one major concern in 
dealing with patients having suspected acute coronary syndrome is the concern of 
overutilization of healthcare resources, which can lead to overcrowding of emergency 
departments and observational units, increased costs of care, and iatrogenic conditions 
experienced by the patients. In 1977, Pozen et al. demonstrated that classification schema from 
that time (e.g. Hutter/Sidel and Killip classifications) were insufficient for risk stratification.  
While they performed well in predicting mortality, they fell short in predicting morbidity of 
patients with myocardial infarctions, and as such were deemed unsuitable for risk stratification 
of patients. The authors developed a prognostic algorithm by performing linear discriminant 
analysis on four variables (age, prior  history of myocardial infarction, location of myocardial 
infarction, and peak creatine phosphokinase), and found that their new method correctly 
identified 74% of patients as either complicated or uncomplicated.  Their conclusion was that 
this performance “…on this small sample size suggest(s) that there probably exists a set of new 
and as yet unframed criteria which represents a ‘best possible solution’ with respect to 
subsequent mortality and morbidity…” (Pozen, Stechmiller, & Voigt, 1977).   
In 1980 the authors demonstrated a mathematical instrument to supplement clinical acumen 
and reduce inappropriate admissions to the coronary care units.  This instrument was tested on 
401 patients over a 10-month alternating month randomized trial design, and was based on the 
nine clinical variables of history of prior myocardial infarction, inversion of T-waves, dyspnea, 
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abnormal versus normal ST segments, chest pain located in lower or midsternum, chest pain as 
primary symptom, prior history of angina, ST segment elevation or depression greater than 
1mm, and abnormal versus normal T waves,     During experimental months, physicians were 
provided with the probabilistic output of the mathematical tool, but were free to either 
incorporate or ignore it when making admission decisions. Comparison of experiment versus 
control months showed increased overall diagnostic accuracy (91% vs. 83%), decrease in 
inappropriate admission (33% vs. 51%), and overall decrease in admission rate to coronary care 
unit (14% vs. 26%), while maintaining the same low rate of inappropriate discharge (3%) (Pozen 
et al., 1980). This methodology used to create this instrument was further explored in a larger 
multicenter trial, where the same process yielded a model with seven included variables 
(chest/left arm pain, patient report of chest pressure, pain or discomfort as primary symptom, 
prior history of myocardial infarction, history of nitroglycerine use for chest pain, 
electrocardiographic ST segment elevation or depression of 1mm or more, ST segment 
straightening, and T wave peaking or inversion). This eleven month trial with two different 
randomization schemes demonstrated a consistent thirty percent decrease in the number of 
coronary care unit admissions, a decline in inappropriate admissions from 44% to 33%, and no 
increase in missed diagnoses of acute ischemic heart disease (Pozen & D’Agostino, 1984).   Of 
their new predictive instrument, the authors said “The ‘art of clinical diagnosis’ has remained 
until recently the sole domain of the master clinician or physicians’ ‘physician’. The instrument 
in essence attempts to quantify the physicians’ qualitative assessments and, by so doing, 
improve their diagnostic accuracy and admission decisions. By complementing the standard 
process of clinical reasoning, the instrument may be more acceptable to physicians than are 
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algorithms that reduce the diagnostic process to a finite series of decision points.  In addition, 
the instrument is preferable to ordinal scales that counterintuitively dichotomize patients into 
‘intervention’ versus ‘nonintervention’ at preset ‘cutoff’ points.”(Pozen et al., 1980) 
Over the next years, this particular model would be modified and continually studied by Selker 
et al. (Selker, D’Agostino, & Laks, 1988).   In 1988, this model was extended into a handheld 
calculator and trialed prospectively in 2320 patients seen during an 11-month trial period.  Due 
to the design of the experiment, 1288 patients were seen during experimental time periods and 
1032 were seen during control time periods. During experimental times, as in prior work by 
Pozen, there was a 30% reduction in admission rates to the coronary care unit, with no 
decrease in the rate of correct admissions for patients with coronary ischemia.  One final aspect 
of this study was the incorporation of the model into the electrocardiogram Of note, some 
of the variables that were previously included were deemed to be too dependent on 
clarification for use with an ECG (history of myocardial infarction, nitroglycerin use, and ST-
segment straightening), which were replaced with factors for age, sex, Q-waves, and greater 
detail in ST-segment changes. ].  Based on area under the receiver operating characteristic 
curve (AUC) measurements, these new modifications were essentially the same in 
discriminating between true and false cases of cardiac ischemia [Selker 1986].  
Perhaps due to their choice of publication journal, Selker et al. again presented results of the 
time-insensitive predictive instrument (TIPI) for acute cardiac ischemia (ACI) in 1991 (Selker, 
Griffith, & D’Agostino, 1991). In 1992, Cairns et al. validated this ECG-incorporated tool in a 
convenience sample of 101 patients, comparing it to unassisted physician assessment. While 
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specificity remained essentially the same between physician triage decision and the TIPI score, 
sensitivity rose from 77% to 93%, and the AUC increased for the prediction of acute myocardial 
infarction from 0.64 for physician assessment to 0.85 for the TIPI score (Cairns, Niemann, 
Selker, & Laks, 1992). In 1998, another large controlled trial across 10 hospitals across the 
United States demonstrated the ability of this  automatically generated score to affect change 
in admission patterns, accounting for a 50% decrease in admissions to the coronary care units, 
a 10% increase in discharges to home, and, where  telemetry units were common, a reduction 
in telemetry unit admissions of 14%, while still not reducing the rate of appropriate admission 
from that achieved by the physician without assistance. (Selker et al., 1998)At least five other 
prospective clinical trials have validated, to some extent, the performance of the ACI-TIPI 
[Seyal, Miller, Mitchell, Kellett](Ilgen et al., 2011). A projection of potential impact on care and 
malpractice claims by the ACI –TIPI was performed in 2002, suggesting that use of the 
instrument as a means of defensive medicine could potentially save the United States over $12 
billion in malpractice costs, though there are obvious caveats to this interpretation (Selker et 
al., 2002).  One study in particular, however, determined the ACI-TIPI to have lower 
discriminatory power than previously reported (AUC=0.69), but still suggested that there may 
be used in referring to the score, as patients with a score over 20 contained all instances of ACS, 
leading the authors to believe that a score of less than 20 may denote a subset of the 
population that is safe for early discharge (Ilgen et al., 2011). This assumption remains to be 
tested. Finally, at least one study of ACI-TIPI use by Emergency Medical Service (EMS) providers 
has demonstrated that use of the tool improves performance of paramedics to identify ACS and 
increases the proportion of patients who receive percutaneous coronary intervention.  
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However, to achieve these results, the authors suggest that the output of the ACI-TIPI may 
need to be translated into a cutoff value, directly opposing some of the early views about the 
value of full probabilistic representation of the score. (Selker et al., 2011)  
Goldman Score 
At the same time as much of the work that would become the ACI-TIPI, Goldman and 
colleagues also set out to develop a model to aid in the diagnosis of patients with acute chest 
pain in the emergency department. The rule was designed to classify patients as either having 
acute myocardial infarction or not, and used recursive partitioning techniques to reach a 
conclusion. It  was originally derived on a cohort of 482 patients who presented with non-
traumatic chest pain and were at least 30 years of age, and the clinical variables determined to 
be of importance were age, length of symptoms, primary location of pain, diaphoresis, previous 
history of angina and if this pain was worse than previous times, reproducibility of the pain by 
local pressure, the presence of ST-segment elevation or Q waves not known to be old, and the 
presence of other ST-segment or T-wave changes suggestive of ischemia not known to be old. 
Of note, the Goldman rule included no laboratory results for biomarkers.  On the derivation set, 
the Goldman rule achieved 100% sensitivity for acute infarction and a specificity of 80%. In a 
separate prospective validation set from the initial publication, the performance of this model 
integrated with physician decisions achieved an increase in specificity for non-infarction (77% 
vs. 67% without model) and increased overall accuracy (79% vs. 71% without model) while not 
losing much in the way of sensitivity (Goldman et al., 1982).  
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The Goldman rule was further adapted in a set of 1379 patients from two different hospitals, 
and prospectively validated on a population of 4770 patients from these same two hospitals. In 
the validation set, this rule performed similarly to how it had during the derivation phase. 
Further, the authors of this study suggested that previous work by Pozen (Pozen et al., 1980) 
had succeeded in modifying the clinical practice of physicians but paid no attention to the 
accuracy of their predictions, while this study’s authors were more concerned with the 
predictive capabilities of their instrument.  In turn, concerns raised about the Goldman rule 
included the validity of comparing physician admission decisions to decisions made by the 
computer rule (real world vs. idealized world), the concern that the rule may only be used in 
practice on patients for which the decision is less clear (spectrum bias) and the inherent 
acceptability of the rule to disagree with physician assessment. One opponent of the rule 
suggested “Asking a physician to use the Goldman protocol for any given case is analogous to 
requesting that he or she consult a colleague who has approximately equal skill, answers with 
only one word or a numerical probability, and disagrees (with them) 21 percent of the time.” 
(“Computer-derived protocol to predict myocardial infarction in patients with chest pain.,” 
1988). Despite these concerns, the Goldman protocol has still been studied as a potential 
means to predict risk of emergency room patients with chest pain.  Grijseels et al. compared 
several algorithms for use in pre-hospital triaging, including the Pozen model form 1984 and the 
Goldman model from 1988. These authors determined that neither these models nor the other 
model examined were suitable for predicting acute cardiac pathology in pre-admission patients 
(Grijseels et al., 1995). In 2011,  Limkakeng et al. showed that the Goldman score, in 
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combination with troponin measurements, could not identify a subgroup of patients with a 
sufficiently low risk of major events suitable for early discharge (Limkakeng & Gibler, 2001). 
TIMI Risk Score 
Perhaps the most widely known, used and studied of the prognostic indices, the Thrombolysis 
in Myocardial Infarction (TIMI) risk score for unstable angina and non-ST elevation myocardial 
infarction was first published in 2000 by Antman et al. and derived from a cohort of patients 
from the TIMI 11B trial (Antman & Cohen, 2000). It was designed to be clinically meaningful in 
predicting mortality or major complications over 14 days as well as very simple to calculate; 
while multivariable logistic regression with backward elimination was used to build a 
mathematical representation, the risk score was designed to contain only the seven clinical 
variables with significant effects on outcome, each of which contributing a maximum of one 
point to the overall seven point score.  The variables included in the score are age greater than 
65 years, at least three risk factors for coronary artery disease, significant priory coronary 
stenosis, ST deviation on ECG, severe anginal symptoms (2 events occurring in the past day), 
the use of aspirin in the past 7 days, and elevated serum cardiac markers. Even in the original 
publication, the reported performance of the score on the validation set of 1957 patients was 
less than ideal (AUC =0.74 for all-cause mortality, AUC=0.63 for mortality/myocardial 
infarction). That said, the TIMI score has been praised for its simplicity, and continues to be 
studied as a means of guiding admission and treatment decisions for patients with suspected 
ACS. Work by Pollack et al. suggested that the TIMI risk score could be applied to an unselected 
cohort of chest pain patients (Pollack, Sites, Shofer, Sease, & Hollander, 2006). Many 
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prospective validation studies have taken to modifying the original TIMI score to include newer 
and readily available biomarkers, or to allow a more inclusive definition of ischemic changes on 
ECG (Body, Carley, McDowell, Ferguson, & Mackway-Jones, 2009; Chase et al., 2006; Hess et al., 
2010; Jarai et al., 2007).  
A discussion of comparisons between the TIMI risk score and other prognostic indices is 
presented later in this chapter. 
PURSUIT Score 
Also in 2000, Boersma et al. presented a risk score derived from baseline characteristics of 9461 
patients with acute coronary syndromes without ST-segment elevation derived from 
enrollment in the Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using 
Integrilin (eptifibatide) Therapy (PURSUIT) trial (Boersma et al., 2000). The score was derived 
via multiple logistic regression with backwards stepwise selection, but unlike the TIMI score, 
allowed for graded responses for the different clinical variables.  For example, the feature of 
age can contribute between 0 and 6 points to the 18-point score for predicting mortality, 
depending on the decade of the life in which the patient presents.  The variables included in 
this score are age, sex, the Canadian Cardiovascular Society class based on heart failure 
symptoms, heart rate, systolic blood pressure, the presence of rales on examination, and the 
presence of ST-depression on ECG. The PURSUIT score performed reasonably in predicting 
mortality (AUC=0.804 on bootstrapped sample), though not as well on predicting a composite 
endpoint of death or MI (AUC=0.669 on bootstrapped sample). While the PURSUIT score is well-
known, it is seldom used in guiding triage or treatment decisions in the emergency department.  
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A discussion of comparisons between the PURSUIT risk score and other prognostic indices is 
presented later in this chapter. 
GRACE Score 
The Global Registry of Acute Coronary Events (GRACE) score was published in 2003 (Granger et 
al., 2003). Unlike TIMI and PURSUIT scores, which were developed on cohorts from clinical 
trials, the GRACE score is derived from patients in a registry, where no experimental treatment 
was explored. However, patients in this registry were required to have received a final diagnosis 
of ACS, and patients were included in the registry only if they had ECG changes suggesting ACS, 
serial increase in cardiac enzymes, or documented coronary artery disease. Like TIMI and 
PURSUIT, the underlying model for the GRACE score was a multivariable logistic regression 
feature selection performed by backwards elimination, and then a more intelligible score was 
produced from this model. However, the GRACE score allowed for even more gradation of each 
individual predictor than the PURSUIT score, and one critique against the GRACE score is that its 
calculation is too complex to be performed without a computer.  Included variables were the 
Killip class of heart failure, systolic blood pressure, heart rate, age, creatinine, and presence or 
absence of cardiac arrest at admission, ST-segment deviation, and elevated cardiac enzyme 
levels.  The score was developed in 11389 patients, and subsequently validated on cohorts of 
3972 and 12142 patients.  The performance in these validation cohorts were respectable 
(AUC=0.84 and 0.79, respectively).  While the original GRACE model was developed for 
predicting in-hospital mortality, additional GRACE-derived models to predict mortality and 
myocardial infarction over longer durations following discharge have also been developed 
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(Eagle et al., 2004; Fox et al., 2006).  Like TIMI, some validation models have sought to improve 
the predictive performance of the GRACE model by including additional biomarkers of cardiac 
ischemia severity (Meune et al., 2011). 
Studies Comparing TIMI, PURSUIT and GRACE scores 
Several studies have been undertaken to compare the three previous risk models in terms of 
their ability to predict mortality, final diagnosis of ACS, or complications of unselected patients. 
While some have shown that the risk indices in question may have some value in guiding 
decisions about triage and treatment, many have also highlighted areas where none of the 
scores perform adequately. 
In 2004, Yan et al. demonstrated similar discrimination power between the GRACE and PURSUIT 
risk models in 4627 patient in an observational registry of patients with ACS. While both had 
high discriminatory capacity (AUC = 0.84 for GRACE, 0.83 for PURSUIT), the GRACE model 
significantly outperformed PURSUIT in terms of  calibration, with PURSUIT consistently 
overestimating risks (Yan et al., 2004), leading the authors to suggest that risk models derived 
from clinical trials may perform less favorably in real world studies than risk models derived 
from the more general populations of registries.  
de Aruajo Goncalves et al. compared the performance of  the GRACE, TIMI and PURSUIT risk 
scores for predicting a combined endpoint of death or myocardial infarction at 1 year, well 
beyond the timeframe for which these risk scores were developed. They studied 460 
consecutive chest pain patients who were referred to a coronary care unit. Their findings 
suggested that these models may still have some predictive ability out to the further time 
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horizon of one year, with GRACE outperforming both PURSUIT and TIMI (AUC = 0.715, 0.630, 
and 0.585, respectively). Their conclusions were that these indices could be used to identify a 
high-risk population that would benefit the most from early intensive interventions (de Araújo 
Gonçalves, Ferreira, Aguiar, & Seabra-Gomes, 2005).  
Ramsay et al. compared the TIMI and GRACE scores against physician assessment for predicting 
death, non-fatal myocardial infarction and emergency vascularization within 30 days in 347 
patients with unselected chest pain. The GRACE score outperformed the TIMI score, while both 
outperformed unstructured physician assessment (AUC= 0.82, 0.74, and 0.55, respectively), 
concluding that evaluation based solely on ECG and cardiac biomarker findings at presentation 
were insufficient for predicting risk for chest pain patients (Ramsay, Podogrodzka, McClure, & 
Fox, 2007).  
In 2007, Yan and colleagues compared the performance of the TIMI, PURSUIT and GRACE scores 
in predicting in-hospital and one-year mortality in a prospective multi-center registry trial. For 
both in-hospital and one-year mortality, GRACE outperformed PURSUIT, which in turn 
outperformed TIMI (AUC = 0.81, 0.80 and 0.68 for in-hospital death, respectively; AUC=0.79, 
0.77. 0.69 for one-year death, respectively). The authors posit that the improved performance 
of GRACE and PURSUIT over TIMI may be due to the inclusion of highly significant independent 
variables for hemodynamic stability and renal function, but that this exclusion has also 
rendered the calculations for the TIMI score significantly simpler to perform (Yan et al., 2007).  
Extending the exploration of the relationship between simplicity and performance, Aragam and 
colleagues compared the performance of GRACE and TIMI scores in predicting in-hospital and 
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one-year mortality in an unselected ACS population who were admitted to their study hospital. 
They found similar performance by both GRACE and TIMI scores among the patients with STEMI 
for in-hospital (AUC = 0.84 and 0.83, respectively) and one-year (AUC = 0.72 and 0.71, 
respectively) death. However, among patients who had experienced a UA/NSTEMI, the GRACE 
score significantly outperformed the TIMI score for both in-hospital (AUC = 0.85 vs. 0.54) and 
one-year (AUC= 0.79 vs. 0.56) mortality. They attributed this deficiency in discrimination of the 
TIMI score to the omission of key variables for heart failure and hemodynamic stability, and 
when these variables were added into the model, the performance of the TIMI model in 
UA/NSTEMI patients was markedly improved (Aragam et al., 2009).  
Manini and colleagues demonstrated a major weakness of some of the previously mentioned 
risk models. They compared the TIMI score, Goldman rule, and another model by Sanchis (J 
Sanchis et al., 2005; Juan Sanchis et al., 2005) for their performance in 148 consecutive patients 
with chest pain, a non-diagnostic ECG, and negative initial cardiac biomarkers. In this study, the 
performance of all models was poor, with low sensitivity (35%-53%)  and not insignificant rates 
of acute coronary events in the low-risk populations as determined by the models, ranging from 
8-9% for the various scores (Manini et al., 2009). 
In a group of 931 unselected patients, Filipiak et al. demonstrated high predictive value of the 
GRACE score (AUC = 0.84) over the TIMI score (AUC = 0.63) for predicting one-year mortality. 
Interestingly, another TIMI-derived score developed for patients with STEMI performed as well 
as the GRACE model (Filipiak et al., 2011). 
20 
 
Using a method of “re-binning” the scores from GRACE and PURSUIT to match the 7 point scale 
of the TIMI score, Lee et al. found in a secondary analysis of 4743 patients  with suspected ACS 
that the TIMI score outperformed both the GRACE and PURSUIT scores (AUC= 0.757, 0.728 and 
0.691, respectively) in predicting a composite outcome of death, nonfatal myocardial infarction, 
or revascularization (Lee, Chang, Matsuura, Marcoon, & Hollander, 2011). Though the authors 
do not mention it, it seems that the re-scaling of the GRACE and PURSUIT scores may have 
caused a loss of information, leading to the apparent superiority of the TIMI score. 
A systematic review and meta-analysis of scoring metrics used for the diagnosis of ACS in 2012 
showed that the GRACE score performed best out of the examined scores, with pooled AUC = 
0.82 for short term and AUC = 0.84 for long term follow up. This same analysis revealed pooled 
AUCs for the TIMI score for UA/NSTEMI of 0.54 and 0.67, respectively (D’Ascenzo et al., 2012).  
However, Goodacre and colleagues showed in 2012 in a  retrospective analysis of 2263 patients 
who presented to the emergency department with suspected acute coronary syndromes from 
the Randomized Assessment of Point-of-care Assay of Cardiac markers (RATPAC) trial that the 
scores’ ability to predict composite endpoint of death, myocardial infarction, life-threatening 
arrhythmia, emergency revascularization or hospitalization for acute coronary syndrome 
yielded AUCs for the GRACE and TIMI scores of 0.717 and 0.682 at 30 days, respectively, and 
0.726 and 0.693 at 90 days, respectively. The corresponding AUCs for age alone were 0.656 at 
30 days and 0.689 at 90 days, suggesting little additional information gain from either score 
(Goodacre, Bradburn, Mohamed, & Gray, 2012). 
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Modern Risk Scores 
The following three diagnostic algorithms (Vancouver protocol, HEART score and North 
American Chest Pain Rule) are considered by many in the field of emergency cardiology to be 
state of the art in practical and useful tools to help assess chest pain in the emergency 
department.  
Vancouver Rule/Vancouver Diagnostic Algorithm 
In 2006, Christensen et al. presented a rule for determining the appropriateness of early 
discharge in emergency room patients deemed to be at low risk for acute coronary syndromes. 
From their own data, they identified that 5.4% of patients with acute coronary syndrome were 
erroneously sent some, while less than 30% of patients without acute coronary syndrome were 
discharged less than three hours after admission, which they saw as a great waste of resources 
(Christenson et al., 2004). As a result, the goal of the study was to develop a clinical prediction 
rule to allow the identification of a subset of chest pain patients suitable for discharge within 2 
to 3 hours what would miss fewer than 2% of acute coronary syndrome cases, while still 
allowing at least 30% of patients to be discharged by the rule. Interestingly, this one of the first 
clinical decision protocols specifically designed for rule-out purposes for patients with 
suspected acute coronary syndrome (Christenson et al., 2006).  
The rule developed from this study relied on a recursive partitioning model to determine which 
of the potential 123 risk variables or combinations of variables could be used to safely discharge 
patients from the emergency department. Of note, the author’s pre-selected only the variables 
that had a univariate association with the outcome variable (p<0.2). The approach used by the 
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authors also assigned a 10-fold higher penalty to a false negative, or incorrectly discharging a 
patient with acute coronary syndrome, than they did to a false positive, or wrongfully admitting 
a patient without acute coronary syndrome. The final model considered patients to be low-risk 
if they were less than 40 years of age and had normal initial ECG and no history of prior 
ischemic chest pain, or if they were over 40 years of age with normal ECG results, no history of 
previous ischemic chest pain, did not have radiating pain or pain that increased with breathing 
or palpitation, and a normal initial CK-MB level or an unchanged CK-MB level at 2 hours. The 
resulting model was highly sensitive, identifying all but 2 of the 165 definitively-diagnosed cases 
of acute coronary syndrome. It was subsequently prospectively validated on a cohort of 593 
patients presenting to an emergency department with a chief complaint of acute chest pain, 
where nearly half (292/593) of the patients would have been eligible for early discharge, and 
the rate of ACS events in those who would have been discharged was 1.4% (4/292 patients) 
(Jalili, Hejripour, Honarmand, & Pourtabatabaei, 2012). 
Though not explicitly linked to the Vancouver rule, the Vancouver Chest Pain Diagnostic 
Algorithm (Scheuermeyer et al., 2012) almost certainly built on previous work done at many of 
the same institutions. This diagnostic algorithm was designed to determine which low-risk chest 
pain patients could be managed as outpatients after only 2 to 6 hours of emergency evaluation, 
and patients were considered low-risk by this approach if they did not have the following high 
risk variables: pain similar to prior acute coronary syndrome event, pain at rest for greater than 
20 minutes, continued pain in the emergency department, typical crescendo angina, change in 
an existing anginal pattern, new cardiac murmur, evidence of heart failure, new hemodynamic 
instability, ECG results suggestive of ischemia, or an elevated cardiac troponin.  By this 
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algorithm, 845 of the 1140 enrolled patients could be discharged within six hours of 
presentation, with 266 of these patients advised to return for follow up within 48 hours. Among 
the total 845 patients, there were no cases of patients discharged from the emergency 
department with non-ACS diagnoses without 48-hour follow up who were proved to have acute 
coronary syndrome or an adverse event at 30 days. While this study was tested on one cohort 
at one center, the excellent performance of the protocol suggests that there may not only be a 
subset of variables which designate patients with ACS from those without, but that determining 
the most appropriate way to manage the care of patients with suspected ACS may be just as or 
more successful at impacting resource use and overcrowding.  
HEART Score 
In 2008, Six, Backus and Kelder presented their new scoring index for predicting risk of major 
events for patients presenting to the emergency department with chest pain.  Interestingly, 
their method was not focused on mathematical associations between findings and outcomes, 
but solely on clinical knowledge.  Their score consists of points for five different categories 
which form the acronym of the score’s name: History, ECG results, Age, Risk Factors and 
Troponin.  More than many other prognostic indices, this score relies heavily on subjective 
interpretation of findings by the physician. For instance, points are added to the sub-score for 
history based on whether the patient’s presentation is “highly suspicious, moderately 
suspicious, or slightly suspicious” for acute coronary syndrome. Similarly, one or two points are 
also added to each other sub-score based on the interpretation of findings.  In the derivation 
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cohort, the HEART score performed well, differentiating reasonably well between high- and 
low-risk patients (Six, Backus, & Kelder, 2008) 
Despite its apparent lack of mathematical backing, prospective validation demonstrated that 
the score at least performed well in identifying a population that may be appropriate for early 
discharge; among patients with a HEART score of 0 to 3, less than 1% experienced the 
combined outcome of myocardial infarction, revascularization or death within 6 weeks of 
presentation. This is in contrast to patients with a HEART score of 7 to 10, where the outcome 
rate was 65.2% (Backus et al., 2010).  Furthermore, in direct comparison to the TIMI and GRACE 
scores, the HEART score outperformed the other metrics in terms of discrimination, with an 
overall AUC of 0.83 vs. 0.75 for TIMI and 0.70 for GRACE(Backus et al., 2013) . 
North American Chest Pain Rule 
The North American Chest Pain Rule (NACPR) was proposed by Hess et al. (Hess et al., 2012). 
Like the Goldman rule, the NACPR was based mathematically on recursive partitioning, and 
yielded a prediction rule that labeled patients as low-risk if they lacked five clinical variables: 
suspected new ischemic changes on ECG, previous history of coronary artery disease, pain 
typical for acute coronary syndromes, initial or 6-hour troponin greater than the 99th percentile 
of normal, and age greater than 50 years. This rule was validated by internal bootstrap 
validation, and produced a rule that was in the derivation set 100% sensitive for major cardiac 
event at 30 days. 
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Accelerated Diagnostic Protocols 
While not risk stratification indices of themselves, an approach that is gaining popularity is the 
accelerated diagnostic protocols (ADPs). These protocols are designed to allow for rapid rule-
out of patients who present with chest pain or other symptoms raising suspicion of ACS but 
who ultimately are determined to have a non-cardiac etiology for their complaints, while still 
maintaining a high degree of sensitivity for true ACS cases. These protocols typically involve 
combinations of risk stratification scores, electrocardiographic interpretation and cardiac 
marker analysis, and take place over 6 to 12 hours after the patient presents to the emergency 
department, with the hope being that treating the patient via the pathway will help make it 
clear which patients can reasonably be discharged home sooner.  (Than et al., 2011, 2012). 
While accelerated diagnostic protocols represent one of the cutting edges in emergency 
department healthcare delivery research, it should be mentioned that some respected 
cardiologists are hesitant to accept them as superior other risk stratification tools or 
unstructured risk estimates.  It cannot be argued, however, that while many prognostic models 
focusing solely on risk prediction may be useful in the hands of a trained provider, accelerated 
diagnostic protocols are explicit in their proscriptions for managing patients with varying risk 
profiles, removing much of guesswork and reducing variation between physicians of various 
levels of training.  
Computational Models 
Although not entirely self-contained as a line of research, the higher-complexity computational 
models are being presented as a unit to demonstrate the similarities in their derivation. By 
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computationally complex, we mean models that rely on more complex mathematics and 
modeling than logistic regression.  In the arena of diagnosing patients with potential acute 
coronary syndrome, this has most often been the artificial neural network (ANN), a complex 
non-linear model based on the concept of animal neural circuitry. Just as in neuroscience, the 
nodes of theses network, analogous to neurons, receive signals from other neurons, and, if the 
total input is sufficient to pass along a signal, fire a message to the next neuron in line. This 
model is different from logistic regression in that it can model complex interactions between 
variables, but it is often difficult to interpret the output of the model or the importance of any 
individual variable in isolation.  
In 1990, Baxt first published on what would become a repeated pattern in his research career: 
the utilization of an artificial neural network for the diagnosis of acute cardiac events in one 
way or another. The model from this first paper was designed to distinguished patients who 
had experienced acute myocardial infarction from those who had not in a high-risk, coronary 
care unit population from which significant data had been obtained. The data was obtained 
from a retrospective chart review, and the many variables collected related to the four main 
categories of history of present illness/demographics, past history, physical examination, and 
electrocardiographic findings.  From this chart review, these findings were translated into 
binary variables, where 1 signified that the finding was present, and 0 signified that the finding 
was not present. The ANN was trained on 178 binary-coded patient records, and tested on a 
separate set of 178 patient records, of which it correctly identified 92% of patients with acute 
myocardial infarction, 96% of patients without, and still maintained an accuracy of 80% when 
all ECG data was removed (Baxt, 1990).  To prospectively validate this model, Baxt retrained the 
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model on the entire data set from the retrospective study and prospectively testing the 
performance on a new cohort of 331 individuals presenting to the emergency department with 
anterior chest pain, on which the network performed with higher sensitivity (97.2% vs. 77.7%) 
and specificity (96.2% vs. 84.7%) compared to physician assessments in predicting presence of 
acute myocardial infarction(Baxt, 1991). He also explored parallelized network analysis, using 
the output of one network to decide the initial input of a subsequent network (Baxt, 1992a). In 
1996 and 2002, this network technique was prospectively validated, both for the identification 
of patients with myocardial infarction (Baxt, Shofer, Sites, & Hollander, 2002a; Baxt & Skora, 
1996) and more generally, acute coronary syndromes (Baxt, Shofer, Sites, & Hollander, 2002b). 
Baxt’s research also demonstrated interest in the mechanisms behind the networks.   In 1992, 
his continued work on the ANN described above demonstrated that the trained network 
seemed to placing significance on variables that were different than the ones considered to be 
predictive of risk by experienced clinicians(Baxt, 1992b). Continued work in this vein 
demonstrated that one plausible reason for this deviation from recognized clinically-important 
data was that the non-linear network was identifying relationships between the unexpected 
variables and the other variables present for an individual patient, which he described as the 
“context” for the variables.  In this way, unexpected interactions between multiple variables 
seemed to improve the performance of the model based on unanticipated relationships among 
all of the variables, not just the ones deemed clinically relevant by expert opinion (Baxt, 1994).  
At the same time much of this work was being done, a research team led by Kennedy and 
Harrison were also exploring ANNs for the purpose of diagnosing acute myocardial infarction 
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and acute coronary syndromes, while also exploring whether simpler models could perform 
nearly as well. Their conclusions, from a long period of research, were that any model would 
not be able to perform perfectly “because the available data are not perfectly predictive for 
myocardial infarction and because there is a considerable overlap in clinical and ECG features of 
patients with myocardial infarction and those with acute coronary syndromes without 
myocardial infarction.” (Harrison & Kennedy, 2005).  Interestingly, they also found that, in their 
experience, a logistic regression model could perform nearly as well or as well as a more 
computationally-demanding ANN (Kennedy & Harrison, 2006).  This was in contradiction to 
findings by Green and colleagues near the same time (Green, Björk, & Forberg, 2006). 
Two other methods of computational model building used at least once in the diagnosis of ACS 
that are worth mention are the genetic algorithm for variable selection published by Vinterbo 
(Vinterbo & Ohno-Machado, 1999) and the averaged one-dependence estimator known as the 
AMIS model published by Kurz (Kurz et al., 2009).  In short, the method described by Vinterbo 
demonstrated different methods of feature selection for logistic regression. This study 
compared forward, backward and bidirectional stepwise elimination with a genetic algorithm 
for determining the most appropriate variables for logistic regression models s for predicting 
the presence of myocardial infarction in emergency room patients with chest pain. 
Interestingly, there were many variables that were selected by the genetic algorithm that were 
not selected by any of the stepwise elimination methods, and several variables which were 
selected by all stepwise methods but not by the genetic algorithm. The regression model built 
with variables determined by genetic algorithm outperformed all other regression models on 
an independent test set (Vinterbo & Ohno-Machado, 1999).  The other study mentioned above 
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presents an averaged one-dependence estimator (AODE) model, which is a simplified version of 
a Bayesian network in which the probability that any given symptom is dependent only on the 
probability that the patient has the disease in question.  Like the GRACE score, this model was 
developed to be a risk model that would apply to patients with all levels of ACS by including all 
levels of presentation in the risk model and not limiting to the more common UA/NSTEMI vs. 
STEMI methods.  The derivation cohort contained 7520 patients from the AMIS (Acute 
Myocardial Infarction in Sweden) registry, which was expanded in 2001 to include patients with 
any subtype of ACS. The AMIS score included the seven variables age, Killip class of heart 
failure, systolic blood pressure, heart rate, pre-hospital cardiopulmonary resuscitation, history 
of heart failure, and history of cerebrovascular disease, and did not include any laboratory or 
electrocardiographic results.  On the derivation cohort of 7520 patients, the AUC achieved was 
0.875.  This result was validated in a separate AMIS cohort (n=2854, AUC=0.868) and a cohort 
from the Krakow-Region ACS Registry (n=2635, AUC=0.842). This is notable for the fact that the 
AODE algorithm is highly efficient, and like traditional logistic regression, achieves its prediction 
without including interaction terms for relationships between variables. 
Limitations of Prior Scoring Methods 
Previous models developed for risk prediction have several inherent limitations. As mentioned 
previously, predictive models developed using data from clinical trials or registries may be not 
representative of a general emergency department patient population.  This is largely due to 
strict inclusion and exclusion criteria used in clinical trials, which causes older and multi-morbid 
patients to be underrepresented.  Registries are also less representative, as requirement for 
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inclusion in many registries is dependent on final diagnosis, making the development of tools to 
screen for disease difficult due to lack of negative examples.  
In addition to the sources of data, the methods of model development are also subject to 
limitations. Almost all previous model creation has included a feature selection step, where 
many of the available data points have been removed from the model, often because of 
insignificant univariate relationship to the outcome.  Recursive partitioning produces models 
that are not robust to perturbations in the training data, and the ability to predict outcomes is 
often not generalizable outside the derivation population. This may also be a problem with 
stepwise selection in logistic regression models, and may account for discrepancies in included 
variables between different models. While so called “black box” models such as ANNs may 
provide superb discrimination between positive and negative examples, they are also subject to 
poor calibration, meaning the predicted probability of outcome often does not correspond with 
the observed probability.  
While there are many available machine learning approaches available, two stand out as 
excellent choices for this task because of the ease with which they can include many variables 
without feature selection, resist overfitting, and provide generalizable performance.  The first is 
the elastic net algorithm, which is regularized logistic regression which combines two penalties 
(L1 and L2) to avoid overfitting while also including a sparsity-inducing penalty, yielding a final 
model which maintains some percentage of the original coefficients, with each coefficient 
decreased in absolute size (Zou & Hastie, 2005). The other is the random forest algorithm, 
which creates an ensemble of decision trees built using different subsets of the variables 
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available for training, and voting the outcome to achieve generalizability of the model to future 
predictions (Breiman, 2001). 
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CHAPTER III 
METHODS 
This section begins with an overview of the data used and is followed by the selected machine 
learning methods applied in this research.  
Data 
We used data derived from electronic medical records for our research. This allowed for two 
points of interest to be explored simultaneously. First, we sought to improve risk stratification 
techniques of patients with potential ACS, by means of identifying as yet unknown predictive 
markers and through the application of different sophisticated machine learning algorithms 
than had previously been used. Second, we hoped that using real patient data might overcome 
the apparent performance problems that limit the utility of previous models, which had been 
largely produced from clinical trial or registry data.  
We obtained the data for this study from Vanderbilt’s Synthetic Derivative (SD) database, which 
is a deidentified copy of the main hospital record databases created for research purposes. The 
deidentificaton of SD records is achieved through the application of an electronic computer 
program, which removes HIPAA identifiers, as well as shifts dates by a random amount of time 
that is unique for each individual’s record.  This study was approved by the Vanderbilt 
University Medical Center Institutional Review Board.  
From this large dataset, we selected 575,642 records of patients who had presented to the 
emergency department between the shifted dates of January 1, 2007 and May 31, 2012. 
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Inclusion criteria were that the patient was at least 18 years of age at the time of presentation 
and that they had a troponin measurement taken within 30 hours of their admit time stamp in 
the transactional table of encounters.  We had planned to capture all patients who presented 
to the emergency department who received a troponin within two or four hours of their 
admission time.  However, due to a peculiarity of the recording system, this was not possible. 
On admission, patient encounter data is generated with the time of admission noted to the 
nearest minute, but that data is overwritten before it is included in the SD, and we resorted to 
the ED admission event that was recorded in a transaction table that only records events with a 
resolution of one day.   
As a result, we selected a study population who had presented to the emergency department, 
as indicated by the transaction table, but who also had an encounter event recorded within the 
consecutive 24 hours following the timestamp for admission.  We then selected further to only 
include patients who had received a troponin within 30 hours of the admission timestamp, 
allowing us to capture all patients who had at least one troponin measurement drawn on the 
same day, or within six hours if they presented close to midnight on any particular day. This 
selection schema  is similar to an approach adopted by (Vaidya, Shapiro, Lovett, & Kuperman, 
2010), who demonstrated their approach in identifying an ACS cohort, and our method yielded 
similar results on our data set as theirs.  As a result, we believe that we captured many, though 
likely not all, of the suspected ACS cases to present to the emergency department during this 
time period.  In total, 23,576 patients were included in this data analysis. No records were 
excluded for missing data. 
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We defined our gold standard label identifying the presence or absence of ACS in our 
population of patients using billing codes found in the patient record.  We used the collection of 
codes proposed by one of the value-based care teams for Vanderbilt University. They define a 
patient with ACS as one who visited the  emergency department for chest pain and who 
received any ICD-9 code listed as an ACS diagnostic code, or any procedure code (ICD-9 or CPT) 
for percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) over the 
thirty days following the admission date.  If a patient was admitted twice within a short amount 
of time, and within thirty days of both visits received a code consistent with ACS, both 
admission instances were considered positive for an ACS event (Table 1). 
 
Table 1: ACS-related codes 
DX DIAGNOSIS_CODE_DESC 
410 
ACUTE MYOCARDIAL 
INFARCT 
410 AMI ANTEROLATERAL WALL 
410 
AMI ANTEROLATRL WALL 
NOS 
410.01 ANTEROLAT AMI-INIT EPISD 
410.02 ANTEROLAT AMI-LATR EPISD 
410.1 AMI ANTERIOR WALL NEC 
410.1 
ANTER AMI NEC-EPISOD 
NOS 
410.11 ANTER AMI NEC-INIT EPISD 
410.12 ANTER AMI NEC-LATR EPISD 
410.2 AMI INFEROLATERAL WALL 
410.2 INFEROLAT AMI-EPISOD NOS 
410.21 INFEROLAT AMI-INIT EPISD 
410.22 INFEROLAT AMI-LATR EPISD 
410.3 AMI INFEROPOSTERIOR 
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WALL 
410.3 
INFEROPOS AMI-EPISOD 
NOS 
410.31 INFEROPOS AMI-INIT EPISD 
410.32 INFEROPOS AMI-LATR EPISD 
410.4 AMI INFERIOR WALL NEC 
410.4 INFER AMI NEC-EPISOD NOS 
410.41 INFER AMI NEC-INIT EPISD 
410.42 INFER AMI NEC-LATR EPISD 
410.5 AMI LATERAL WALL NEC 
410.5 LATRL AMI NEC-EPISOD NOS 
410.51 LATRL AMI NEC-INIT EPISD 
410.52 LATRL AMI NEC-LATR EPISD 
410.6 TRUE POSTERIOR INFARCT 
410.6 
POSTERIOR AMI-EPISOD 
NOS 
410.61 POSTERIOR AMI-INIT EPISD 
410.62 POSTERIOR AMI-LATR EPISD 
410.7 SUBENDOCARDIAL INFARCT 
410.7 
SUBENDO INFRC-EPISOD 
NOS 
410.71 SUBENDO INFRC-INIT EPISD 
410.72 
SUBENDO INFRC-LATR 
EPISD 
410.8 MYOCARDIAL INFARCT NEC 
410.8 AMI NEC-EPISODE NOS 
410.81 AMI NEC-INITIAL EPISODE 
410.82 
AMI NEC-SUBSEQUENT 
EPISD 
410.9 MYOCARDIAL INFARCT NOS 
410.9 AMI NOS - EPISODE NOS 
410.91 AMI NOS-INITIAL EPISODE 
410.92 
AMI NOS-SUBSEQUENT 
EPISD 
411 OTH AC ISCHEMIC HRT DIS 
411.1 
INTERMED CORONARY 
SYND 
411.8 AC ISCHEMIC HRT DIS NEC 
411.81 
CORONARY OCCLUS'N-
ACUTE 
411.89 AC ISCHEMIC HRT DIS NEC 
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413 ANGINA PECTORIS 
413 ANGINA DECUBITUS 
413.1 PRINZMETAL ANGINA 
413.9 ANGINA PECTORIS NEC/NOS 
414 OTH CHR ISCHEMIC HRT DIS 
414 
CORONARY 
ATHEROSCLEROSIS 
414 
CORNARY ATHERO-VESL 
NOS 
414.01 
CORNARY ATHERO-NATV 
VESL 
414.02 
CORNRY ATHER-AUT BYP 
GFT 
414.03 
COR ATHER-NONAUT BYP 
GFT 
414.04 
COR ATHER-ARTERY BYP 
GFT 
414.05 
COR ATHER-UNSPEC BYP 
GFT 
414.2 
CHR TOT OCCL CORONAR 
ART 
414.3 COR ARTHEROSCL D/T LIPID 
414.8 CHR ISCHEMIC HRT DIS NEC 
414.9 CHR ISCHEMIC HRT DIS NOS 
 
We follow the machine learning precedent of using the terms feature and variable 
interchangeably.  Variables to be used in the model were included based on the structure of the 
data, the frequency with which they occurred, and finally on whether they had been proven as 
predictors in previous models. No records were missing patient age. By structure of the data, I 
mean we specifically selected features that were unambiguous in their interpretation and 
collected in a structured (numeric or positive/negative) form rather than an unstructured 
(subjective) form.  As such, many predictors that had previously been shown as highly 
predictive, such as quality of pain, length of pain symptoms, and even qualitative interpretation 
of ECG readings, were not available to our model.  We collected many known risk factors for 
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ACS, including age, sex, race, height and weight, blood pressure, etc.  We also collected many 
laboratory values, some of which have been shown to be associated with ACS, and some of 
which have not previously been identified as predictors. We included any laboratory finding 
that was recorded within at least 2000 of our population subjects, and for all laboratory 
findings we included only the first instance of that finding within their medical encounter. We 
included troponin I and ECG measurements, and where possible, the first two measurements 
for each and the change in troponin level from first to second reading. We also included history 
of certain past medical histories or drug use, such as previous heart disease, hyperlipidemia, 
diabetes, aspirin use or smoking status, which we represented as a binary feature denoting if 
the feature was present prior to this encounter. Finally, any laboratory values that we had not 
included due to low frequency but for which there could be a strong case for inclusion based on 
literature were also included in the model. While we performed little data quality assurance, 
we did modify the heights and weights found in these files to be reasonable, according to the 
most recent anthropometric data from the Centers for Disease Control (Ogden, Ph, & Flegal, 
2008).  All other data, regardless of the potential severity of misrepresentation or nonsense, 
was not assessed or modified. The list of 88 included features can be found in Table 2.   
These features, a label for final diagnosis of ACS, and a compound identifier of synthetic patient 
medical record number and shifted date of admission were structured into feature vectors, 
with each row of the data table representing one instance of an emergency room encounter for 
suspected ACS.  We found variable missingness in the data, ranging from less than one percent 
missing for glucose measurement to greater than 90 percent missing for total protein (Table 2).   
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Table 2: Features included for model creation 
Feature Label Negative Label Positive 
  Non Missing Missing Non Missing Missing 
Age 59 (47-72) NA 66 (56-76) NA 
Gender 47% Male 1.30% 61% Male <1% 
Race 67%White <1% 77% White <1 % 
Height (cm) 170 ( 162 - 178) 78% 172 (165-180) 59% 
Weight 79.7 (66.9 - 95.9) 78% 82.9 (69.8 - 
98.7) 
59% 
Glucose 113 (97 - 146) <1% 121 (101-163) <1% 
Systolic BP 129 (112 - 148) 31% 130 (113- 148) 10% 
Diastolic BP 71 (60 - 83) 31% 70 (59 - 80) 10% 
Pulse 85 (73 - 100) 84% 80 (73 - 95) 82% 
Respiratory Rate 18 (16 - 20) 82% 18 (16 - 20) 82% 
White Blood Cells 8.5 (6.5 - 11.6) 2% 8.5 (6.7 - 11.2) <1% 
Packed Cell Volume 39 (34 - 43) 2% 39 (34 - 42) <1% 
Platelet Count 228 (79 - 286) 2% 220 (175 - 274) <1 % 
Red Blood Cells 4.4 (3.8 - 4.8) 2% 4.3 (3.8 - 4.7) < 1% 
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Mean Corpuscular Volume 89 (85 - 93) 2% 90 (86 - 94) <1% 
Mean Corpuscular Hemoglobin 29.8 (28.2 - 31.2) 2% 29.9 (28.3 - 
31.3) 
<1% 
Mean Corpuscular Hemoglobin 
Concentration 
33.2 (32.2 - 34.2) 2% 33.1 (32.0 - 
34.0) 
<1% 
Red Cell Distribution Width 14.2 (13.3 - 15.6) 2% 14.1 (13.3 - 
15.6) 
<1% 
Standard Deviation of Red Cell 
Distribution Width 
46.4 (43.2 - 51.3) 31% 46.9 (43.7 - 
51.8) 
30% 
Absolute Neutrophils 5.7 (3.8 - 8.5) 12% 5.7 (4.2 - 8.2) 9% 
Percent Neutrophils 69 (5.9 - 79) 12% 69 (60 - 78) 9% 
Absolute Lymphocytes 1.6 (1.1 - 2.3) 12% 1.6 (1.1 - 2.2) 9% 
Percent Lymphocytes 20 (12 - 30) 12% 19 (12 - 27) 9% 
Absolute Monocytes .63 (.46 - .88) 12% .67 (.50 - .89) 9% 
Percent Monocytes 7.6 (5.9 - 9.5) 12% 7.9 (6.2 - 9.8) 9% 
Absolute Eosinophils .10 (.04 - .20 12% .13 (.06 - .23) 9% 
Percent Eosinophils 1.3 (0.5  - 2.6) 14% 1.6 (0.7 - 2.9) 11% 
Absolute Basophils .03 (.02 - .04) 14% .03 (.02 - .04) 11% 
Percent Basophils .3 (.2 - .5) 14% .3 (.2 - .5) 11% 
Nucleated Red Blood Cells 0 (0 - 0) 32% 0 (0 - 0) 30% 
Nucleated Red Blood Cells per 1000 0 (0 - 0) 32% 0 (0 - 0) 30% 
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cells 
Blood Urea Nitrogen 16 (11 - 24) 1% 19  (13 - 29) <1% 
Hemoglobin 12.8 (11.2 - 14.3) 2% 12.7 (11.1 - 
14.2) 
<1% 
Sodium 138 (136 - 140) 1% 138 (136 - 1400 <1% 
Potassium 3.9 (3.4 - 4.3) 1% 4.0 (3.6 - 4.4) <1% 
Chloride 104 (100 - 107) 1% 104 (100 - 107) <1% 
Carbon Dioxide 25 (23 - 27) 1% 25 (23 - 27) <1% 
Brain Natriuretic Peptide 205 (65 - 597) 67% 330 (110 - 896) 52% 
Creatinine 1.06 (0.84 - 1.47) 15% 1.20 (0.95 - 
1.71) 
<1% 
Calcium 9.1  (8.7 - 9.4) 15% 9.1  (8.7 - 9.4) <1% 
Anion Gap 9 (7 - 11) 15% 9 (7 - 11) <1% 
Total Protein 6.5 (5.9 - 7.1) 90% 6.4 (5.8 - 6.9) 90% 
Albumin 3.4 (2.9 - 3.8) 86% 3.4 (3.0 - 3.8)  88% 
Alkaline Phosphatase 78 (61 - 104) 50% 76 (60 -99) 49% 
Aspartate Aminotransferase 27 (21 - 41) 49% 27 (21 - 39) 48% 
Alanine Transaminase 21 (15 - 34) 50% 21 (15 - 32) 49% 
Creatine Kinase - MB Portion 2.27 ( 1.47 - 3.99) 19% 2.71 (1.72 - 
4.76) 
10% 
Creatine Phosphokinase 90 (52 - 171) 2% 91 (54 - 162) <1% 
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Lipase 25 (19 - 36) 78% 26 (19 -37) 80% 
MB – Ratio 2.2 (1.3 - 3.5) 21% 2.8 (1.8 - 4.6) 12% 
International Normalized Ratio 1.2 (1.0 - 1.6) 59% 1.2 (1.0 - 1.8) 52% 
Urine Specific Gravity 1.015 (1.01 - 
1.02) 
49% 1.014 (1.01 - 
1.02) 
53% 
Thyroid Stimulating Hormone 1.79 (1.02 - 3.21) 76% 1.76 (0.97 - 
2.99) 
77% 
Estimated Glomerular Filtration Rate 69.5 (46.8 - 90.2) 2% 59.6 (39.4 - 
79.5) 
2% 
ECG 1 - Heart Rate 84 (71 - 99) 42% 79 (68 - 94) 37% 
ECG 1 - PR Interval 156 (138 - 176) 42% 160 (140 - 184) 37% 
ECG 1 - QRS Duration 92 (82 - 106) 42% 96  (86 - 114) 37% 
ECG 1 - QT Interval 452 (431 - 476) 42% 458 (434 - 486) 37% 
ECG 1 - P Wave 48 (17 - 65) 42% 43 (0 - 620 37% 
ECG 1 - Initial 40 ms  29 (6 - 50) 42% 19 (-4 -47) 37% 
ECG 1 - Mean QRS 21 (-11 - 54) 42% 14 (-22 - 51) 37% 
ECG 1 - Terminal 40 ms 29 (-24 - 54) 42% 28 (-32 - 93) 37% 
ECG 1 - ST Segment 73  (28 - 146) 42% 114 (52 - 175) 37% 
ECG 2 - Heart Rate 82 (70 - 100) 77% 79 (66 - 94) 63% 
ECG 2 - PR Interval 156  (136 - 176) 77% 161 (140 - 184) 63% 
ECG 2 - QRS Duration 92 (84 - 104) 77% 96 (86 - 112) 63% 
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ECG 1 - QT Interval 454 (432 - 478) 77% 460 (433 - 478) 63% 
ECG 2 - P Wave 45 (11-64) 77% 43 (0 - 62) 63% 
ECG 2 - Initial 40 ms  28 (5 - 50) 77% 18 (-5 - 45) 63% 
ECG 2 - Mean QRS 19 (-14 - 52) 77% 13 (-21 - 50) 63% 
ECG 2 - Terminal 40 ms 26 (-26 – 88) 77% 24 (-31 - 89) 63% 
ECG 2 - ST Segment 73 (26 - 152) 77% 111 (51 - 175) 63% 
Smoking History 21% NA 33% NA 
History of Diabetes 28% NA 41% NA 
History of Hyperlipidemia 36% NA 65% NA 
History of Hypertension 55% NA 73% NA 
History of CABG 1% NA 9% NA 
History of PCI 3% NA 27% NA 
History of MI 26% NA 68% NA 
History of CAD 26% NA 68% NA 
History of Stroke 18% NA 30% NA 
History of Heart Failure 23% NA 44% NA 
History of Aspirin Use 49% NA 76% NA 
History of Metoprolol Use 49% NA 76% NA 
History of Nitroglycerin Use 25% NA 56% NA 
Troponin 1 .02 (.01 - .04) NA .04 (.02 - 10) NA 
Troponin 2 .02 (.01 - .05) 6% .04 (.02 - .13) 2% 
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Troponin 2 minus Troponin 1 0 (0.0 - 0.0) 6% 0 (-0.01 - 0.0 ) 2% 
 
Machine Learning 
The original data set was divided into a training set (18,860 records, 80%), a test set for 
evaluating the performance of the different algorithms on data unseen during the training 
phase (2358 records, 10%), and a final validation set (2358 records, 10%), which would be used 
on the highest performing algorithm.  The proportion of positive cases within each division 
remained unchanged.   Missing values in the data were then replaced by the mean value for 
that feature among the individuals within the respective data divisions. Analysis was carried out 
using R version 2.11.1 and downloaded packages randomForest, glmnet, ROCR, Epi and rms. 
We explored the prognostic ability of random forests and Elasticnet, two state of the art 
machine learning algorithms gaining notoriety for their wide use and ease of implementation.  
We also explored L2 penalized regression, also ridge regression, which has been shown to be a 
good benchmark for classification studies. For algorithms requiring parameter tuning, an 
additional step of ten-fold cross-validation was added onto the training set prior to fitting the 
models. This was done for Elasticnet and ridge regression approaches, for which the lambda 
penalization parameter was selected for each, and the alpha mixing parameter selected for the 
Elasticnet method from a possible subspace of 0 to 1 by intervals of 0.1. We did not cross-
validate the parameters for random forest formally, but trial and error experimentation 
suggested that modifying these parameters would have had little or no effect, so we selected to 
build models with default parameters, except the number of trees, which was set to 1000 per 
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forest.   One hundred bootstrap replicates were performed to fully describe the distribution of 
performance of the algorithms, and we compared the performance o f random forests, 
Elasticnet penalized regression, and L2 ridge regression models built with training data on their 
ability to discriminate between previously unseen positive and negative instances in the test 
data set.  Comparisons were made on the basis of AUC and by visual inspection of ROC plots.   
We also sought to compare the performance of these algorithms against two established 
prognostic indices, the TIMI and GRACE scores .  A prior study demonstrated a method for 
imputing missing features for these scores, though their study dealt with data having 
significantly fewer missing values (Goodacre et al., 2012).  For both the TIMI and GRACE scores, 
features that were available in our data set were included and appropriately transformed to the 
scale of these scores.  In accordance with the methods of Goodacre et al, data that was 
completely missing was either replaced by a reasonable surrogate, such as any history of aspirin 
past aspirin use replacing aspirin use within the past seven days for the TIMI score, or replaced 
with the most common, most logical replacement, such as all records being considered 
negative for cardiac arrest on admission. As a result, the maximum possible TIMI score available 
in this series is 5 points, and the maximum possible GRACE score is 246 points. These scores 
were also compared to the other algorithms by calculation of AUC and visual comparison of 
ROC plots for their performance on the test data set.  
After determining a model that clearly outperformed the other models, we examined the 
performance of this model on one final validation set of data, to determine a reliable measure 
of the generalizable error for this approach. Also, as this model is intended for potential use in 
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predicting the risk of patients presenting to the clinic, the accuracy of the predictions is 
potentially just as important as the ability for the risk score to differentiate between positive 
and negative cases.  As a final metric of fit, we evaluated the model calibration by means of a 
calibration curve and Brier score, which are established methods of measuring calibration 
(Brier, 1950). 
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CHAPTER IV 
RESULTS 
Over all 100 bootstrap replicates, random forests outperformed all other methods, including 
the TIMI and GRACE scores (Table 3, Figure 1). 
Table 3. Performance of compared algorithms 
Performance of Models in Current Study 
Model AUC 
TIMI 0.750 
GRACE 0.625 
L2 Regression 0.809 
Elastic Net 0.814 
Random Forest 0.885 
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Figure 1. Receiver operating characteristic curves of compared algorithms on the test data. 
 
The elastic net did not significantly reduce the complexity of the model, maintaining 85 of the 
95 coefficients in the full regression model with non-zero coefficients (expansion of categorical 
into binary variables resulted in 95 features for this regression). 
We further explored which features were being selected by the random forest algorithm. We 
present this data in two ways.  In Table 4, we show the number of times each feature was used 
in a tree. As demonstrated by the number of occurrences per feature, any individual feature 
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could be used more than once in any given tree, allowing for more potential split points than 
previous models like TIMI would have allowed. Dividing the number of times each feature was 
used by the number of trees in the forest (1000) yields an average of the number of times each 
feature was used in a tree. This value ranges from 2.73 times per tree for the laboratory finding 
of nucleated red blood cells to 45.79 times per tree for different split points of age. The number 
of times a feature is used is can be considered a proxy for its importance, though this 
relationship is not perfect. Features that have fewer values, such as binary features, tend to be 
chosen as features to split on less, simply because they have only one potential split point 
available. As a result, this is a less than perfect measure of the importance of a feature, but 
some trends, such as age being included very often, fulfill our expectations.   
Table 4. Counts of features used in the random forest for the validation data set 
Feature Counts 
Age 45790 
Gender 8770 
Race 12346 
Height (cm) 21305 
Weight 24982 
Glucose 43080 
Systolic BP 43239 
Diastolic BP 40981 
Pulse 13786 
Respiratory Rate 13055 
White Blood Cells 39775 
Packed Cell Volume 33313 
Platelet Count 42226 
Red Blood Cells 40963 
Mean Corpuscular Volume 34401 
Mean Corpuscular Hemoglobin 39778 
Mean Corpuscular Hemoglobin Concentration 39349 
Red Cell Distribution Width 38891 
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Standard Deviation of Red Cell Distribution Width 36791 
Absolute Neutrophils 38816 
Percent Neutrophils 38363 
Absolute Lymphocytes 39774 
Percent Lymphocytes 38661 
Absolute Monocytes 38737 
Percent Monocytes 39149 
Absolute Eosinophils 35724 
Percent Eosinophils 35295 
Absolute Basophils 23099 
Percent Basophils 24604 
Nucleated Red Blood Cells 2728 
Nucleated Red Blood Cells per 1000 cells 4396 
Blood Urea Nitrogen 36808 
Hemoglobin 39208 
Sodium 32257 
Potassium 36543 
Chloride 34251 
Carbon Dioxide 32708 
Brain Natriuretic Peptide 32869 
Creatinine 41454 
Calcium 36214 
Anion Gap 30457 
Total Protein 8703 
Albumin 10130 
Alkaline Phosphatase 28827 
Aspartate Aminotransferase 27439 
Alanine Transaminase 27597 
Creatine Kinase - MB Portion 42474 
Creatine Phosphokinase 43650 
Lipase 17009 
MB - Ratio 40161 
International Normalized Ratio 24290 
Urine Specific Gravity 26978 
Thyroid Stimulating Hormone 20484 
Estimated Glomerular Filtration Rate 42797 
ECG 1 - Heart Rate 27454 
ECG 1 - PR Interval 24058 
ECG 1 - QRS Duration 25381 
ECG 1 - QT Interval 27944 
ECG 1 - P Wave 24178 
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ECG 1 - Initial 40 ms  29018 
ECG 1 - Mean QRS 27291 
ECG 1 - Terminal 40 ms 26880 
ECG 1 - ST Segment 30671 
ECG 2 - Heart Rate 14523 
ECG 2 - PR Interval 12928 
ECG 2 - QRS Duration 13186 
ECG 1 - QT Interval 15263 
ECG 2 - P Wave 13634 
ECG 2 - Initial 40 ms  15527 
ECG 2 - Mean QRS 14047 
ECG 2 - Terminal 40 ms 14261 
ECG 2 - ST Segment 15725 
Smoking History 5507 
History of Diabetes 5457 
History of Hyperlipidemia 5917 
History of Hypertension 5281 
History of CABG 3784 
History of PCI 6715 
History of MI 4967 
History of CAD 4592 
History of Stroke 5069 
History of Heart Failure 4799 
History of Aspirin Use 3998 
History of Metoprolol Use 3980 
History of Nitroglycerin Use 4950 
Troponin 1 32689 
Troponin 2 33641 
Troponin 2 minus Troponin 1 28632 
 
We also present a variable importance plot, a built-in function of the randomForest package 
which plots the importance of individual variables determined by permutation analysis. This 
works by calculating the error rate for the classification task on the out of bag trees, then 
permuting each predictor variable successively and measuring the error rate, and comparing 
the permuted and non-permuted error rates across all the trees in the forest. This difference is 
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then normalized by the standard deviation of the differences, and the result is plotted. Figure 2 
shows the importance of each variable in the model, given by the mean decrease in Gini index 
observed when permuting the given feature.
 
Figure 2. Variable importance plot for features from the random forest model 
Under permutation analysis, seven features stand out as the useful core (previous history of 
myocardial infarction, previous history of coronary artery disease, previous history of PCI, first 
troponin, second troponin, change in troponin between first and second measurement, and 
age), but with a long tail of others that are less prominent but still important.  In an attempt to 
further understand this finding, we built a random forest model with only the top seven 
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predictors, and also a model with every feature except the top seven predictors. We found that 
the AUC for the model with the seven predictors removed retained a high discriminative 
capacity (AUC=  0.851), while the model with only the top seven predictors also maintained 
high performance (AUC = 0.815) (Figure 3).  
 
Figure 3. ROC Curves for full random forest model, model with only most important variables, 
and model without most important variables. 
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For an unbiased estimate of the generalized error of the algorithm, we ran the previously 
developed random forest model on a final validation set.  We report the AUC for the random 
forest model to be 0.88092, and illustrate the ROC for this model on the validation set (Figure 
4).    
To assess the calibration of the estimates for the random forest algorithm on this data set, we 
created a calibration curve for the performance on the validation set (Figure 5). This result is 
good, but shows room for improvement. In an attempt to improve the calibration of the output 
of the random forest, we used a novel technique proposed by Bostrom (Boström, 2008), in 
which the output probabilities (probability of positive case and of negative case) for each 
instance was scaled dependent on which probability was larger. By utilizing this approach, we 
were able to improve the Brier score from 0.138 to 0.132 (Figure 6). While this is not a large 
improvement in calibration, it shows that there are methods for improving the calibration of 
random forest output in an attempt to make the predictions more accurate and clinically 
meaningful.  
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Figure 4. Performance of random forest on the validation set of data. AUC = 0.881 
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Figure 5. Calibration curve for the validation set of random forest predictions 
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Figure 6. Calibration curve for validation set after calibration procedure 
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CHAPTER V 
DISCUSSION 
We developed a model using the random forest algorithm utilizing a novel clinical database that 
improved upon existing ACS prediction tools.  Over the past six decades, many prognostic 
indices have been developed to aid physicians in the evaluation of patients with suspected ACS.  
Some have been created out of purely clinical expertise, while others have focused on strict 
mathematical approaches for defining a scoring metric. Some have been derived from clinical 
trials data, and others have used registries of patient encounters. This work represents the first 
attempt that we know of to use a data from real patient encounters in the uncontrolled 
environment of a non-trial, non-registry emergency department for the development of such a 
model.  These data more fairly represents the heterogeneous patient population that 
comprises the cohort of suspected acute coronary syndrome cases nationwide. Without 
inclusion and exclusion criteria to skew the distribution toward generally healthier, younger 
individuals, we have captured a broader range of age and pre-existing morbidity other studies 
in this area have been able to do.   
We have also demonstrated that computationally advanced models can potentially outperform 
standard statistical methods.  Our random forests, elastic net penalized regression, and even L2 
ridge penalized regression outperformed previous models developed by stepwise multivariable 
logistic regression.  
One key limitation to this study is the availability of data in the system with which we worked.  
Many of the timestamp entries, in addition to being shifted by the through the de-identification 
process used in creating the Synthetic Derivative, have also had their seconds, minutes, and 
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even hours truncated.  While temporal specificity down to the minute is not important in some 
studies, such as genome-wide association studies or phenome-wide association studies, 
knowing the correct relationship between event times in a complex history of a patient with 
suspected acute coronary syndromes is critical.  
Another limitation of this study is in the definition of positive events in our cohort. The 
definition used relies heavily on work done by one of the value-based care organization at 
Vanderbilt University Medical Center.  If the purpose of the models we build is to identify 
patients who actually have acute coronary syndromes on a biological basis, the WHO accepted 
universal definition of myocardial infarction would likely be a better place to begin, with 
additional considerations made for unstable angina. However, if the purpose is to predict risk of 
major outcomes, such as death or revascularization, which track tightly with a final diagnosis of 
ACS, this approach is likely sufficient, and alternative methods of identifying ACS-positive 
records would have required significant manual chart review.  
Additionally, we were unable to capture the major outcome of death from the current version 
of the Synthetic Derivative database, but future incarnations will almost certainly contain de-
identified copies of the Social Security death index, which will allow another method of 
identifying a major adverse coronary event.  Even without this information, however, our 
methods proved successful, and prior work by other authors have shown that predicting the 
risk of non-fatal events such as non-fatal arrhythmias or revascularization is a more difficult 
task than predicting the risk of death.  Finally, an inability to determine which patients were 
discharged from Vanderbilt but presented again within 30 days to an outside hospital means 
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we may have underestimated the total number of positive events. Use of identified data in the 
future would allow us to consider patients whose ACS event might be unobservable in the 
current research paradigm.  
While the random forest automatically explores complex interactions between variables, these 
interactions must be manually specified in regression-type approaches, no matter how complex 
they are. As it was not clear apriori which interactions were important, and it would be 
intractable to include all possible interactions, we elected not to include interaction terms in 
our models for elastic net and ridge regression. While this may account for some of the 
apparent outperformance of the regression methods by the random forest, we do not think this 
is an egregious scientific decision, as the majority of previously developed models built with 
stepwise-selected multivariable logistic regression also did not include interaction terms. 
However, it remains a possibility that a form of penalized regression with select interaction 
terms could yield a better performing or more intelligible model than a random forest.  
Random forest models, through their complex representation of interactions between 
variables, can very accurately discriminate between positive and negative examples. However, 
determining which individual variables are most important for driving the decision can be 
difficult, because each is not considered independently as in many regression cases.  Rather, 
every variable interacts with every other variable.  In our specific example, removing the top 
seven predictive variables did not strongly impact the AUC of the model, but using those top 
seven variables alone also did not obliterate the model’s discrimination 
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In this application, calibration is important.  Information used to make important medical 
decisions is required to be correct. . In previous evaluations of ANNs, another connectionist 
model like random forests, discrimination was superior to other metrics, while calibration 
suffered (Selker et al., 1997).  Continued research into ways to calibrate the output of black box 
models to reflect the true probabilities associated with the events they predict will remain 
important in models for use in medical practice. 
While the AUC metric is largely used by the medical and machine learning communities as a 
measure of predictive power, it is by no means the only method.  The ability of one model to 
reclassify examples incorrectly labeled by the other approach can provide significantly 
improved performance, even though their AUCs may be virtually identical.  Newer statistical 
tests, such as net reclassification improvement and integrated discrimination improvement, 
may be the next in an ever expanding toolkit of ways to compare accuracy between models 
(Pencina, D’Agostino, D’Agostino Jr, & Vasan, 2008).  One important future direction of this 
current study and studies like it should be to fully characterize the performance differences 
between metrics, determine which metric is most appropriate for the goal in mind, and make 
certain to judge their performance on that metric as well as any others as appropriate.  
If confirmed, this tool could ultimately improve the quality of care by reduction unnecessary 
admissions and discharges of patients with acute chest pain, and help shift the cost curve for 
healthcare that has so heavily weighed on the medical system by addressing one extreme case 
of resource overutilization. Further work is needed to improve methods of model creation, 
validation, calibration, and the development of appropriate decision support implementation.  
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